Helsinn Advanced Synthesis Opens its Largest Dedicated Anticancer Bay

Biasca, Switzerland, July 30 (Korea Bizwire) – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care and rare disease products, announces that its manufacturing subsidiary, Helsinn Advanced Synthesis SA (HAS), which develops and manufactures Active Pharmaceutical Ingredients (APIs), cGMP Advanced Intermediates, High Potency APIs (HPAPIs) and anticancer compounds, has opened its largest dedicated Anticancer [...]